Mexico has received 2.7 million doses of AstraZeneca’s COVID-19 vaccine from the United States, but has not made progress on accessing larger U.S. stocks.
Mexico has received 2.7 million doses of AstraZeneca’s COVID-19 vaccine from the United States, but has not made progress on accessing larger U.S. stocks.
This website, like most media sites, uses small files called cookies to anonymously customize the advertising that you see. Learn more about how we use cookies in our cookie policy.
